Á¦³îǪ·ÎžÇöó½ºÅ¸(Ç÷縣ºñÇÁ·ÎÆæ) Zenol Pro-Top Plaster
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¾Ë¸²:
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù.
Àü¹®/ÀϹÝ
ÀϹÝ
Åõ¸í ¶Ç´Â ¹ÌȲ»öÀÇ Á¡Âø¼º ¹°ÁúÀ» »ì±¸»ö ¸°Æ®Æ÷»ó¿¡ µµÆ÷ÇÏ¿© Á¡Âø¸é¿¡ ÇǺ¹Ã¼¸¦ µ¤Àº øºÎÁ¦
Á¦Á¶È¸»ç
(ÁÖ)³ì½ÊÀÚ
ÆÇ¸Åȸ»ç
(ÁÖ)³ì½ÊÀÚ
Çã°¡Á¤º¸
Á¤»ó
(2020.03.06)
BIT ¾àÈ¿ºÐ·ù
¿Ü¿ë ¼Ò¿°ÁøÅëÁ¦ (NSAIDs : Skin & Mucous Membrane)
º¹ÁöºÎºÐ·ù
264[ÁøÅ롤Áø¾ç¡¤¼ö·Å¡¤¼Ò¿°Á¦ ]
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå
643605870 [ºñ±Þ¿©]
ATCÄÚµå
Flurbiprofen / M02AA19
NDCÄÚµå
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
¼ººÐ / ÇÔ·®
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
÷°¡Á¦
±Û¸®¼¼¸° ,
¸°Æ®Æ÷ ,
¼Ò¸£ºñź¿Ã·¹¿¡ÀÌÆ® ,
½Ç¸®ÄÚ³ªÀÌÁîµåÆú¸®¿¡½ºÅ׸£Çʸ§ ,
¾ÆÅ©¸±°èÁ¡Âø¿ë¾× ,
À̼ÒÇÁ·ÎÇʹ̸®½ºÅ×ÀÌÆ® ,
Á¶ÇÕÇâ·á(Çãºê¹ÎÆ®Çâ19) ,
ÅäÄÚÆä·Ñ¾Æ¼¼Å×ÀÌÆ® ,
Æú¸®¿¡Æ¿·»±Û¸®ÄÝ400 ,
l-¸àÅç
À¯·áȸ¿ø °áÀç½Ã ¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸ ¸¦
ÀÌ¿ë ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
À¯·áÁ¤º¸¸ñ·Ï Àº Àü¹®È¸¿ø À¸·Î
·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
Çã°¡Á¤º¸
Ç׸ñ
³»¿ë
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå »óÇѱݾ×
643605870
[º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸]
[ºñ±Þ¿©]
[»óº´ÄÚµåÁ¶È¸]
[Áúº´ÄÚµåÁ¶È¸]
ºü¸¥Á¶È¸
Á¦Ç°¼º»ó
Åõ¸í ¶Ç´Â ¹ÌȲ»öÀÇ Á¡Âø¼º ¹°ÁúÀ» »ì±¸»ö ¸°Æ®Æ÷»ó¿¡ µµÆ÷ÇÏ¿© Á¡Âø¸é¿¡ ÇǺ¹Ã¼¸¦ µ¤Àº øºÎÁ¦ [Á¦ÇüÁ¤º¸ È®ÀÎ]
Æ÷À塤À¯Åë´ÜÀ§
12 ¸Å/ÆÑ, 48 ¸Å(12 ¸Å/ÆÑ ¡¿ 4)
Æ÷À塤ÄÚµå´ÜÀ§
¾àǰ±Ô°Ý
´ÜÀ§
Æ÷ÀåÇüÅÂ
´ëÇ¥ÄÚµå
Ç¥ÁØÄÚµå
ºñ°í
40¹Ð¸®±×·¥
8 ¸Å
ÆÑ
8806436058705
8806436058729
1¸Å(7x10§², 0.409g)
40¹Ð¸®±×·¥
15 ¸Å
ÆÑ
8806436058705
8806436058712
1¸Å(7x10§², 0.409g)
ÁÖ¼ººÐÄÚµå
161902CPL
[µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
Çã°¡»çÇ× ¿ø¹®Á¶È¸
[Çã°¡»çÇ× ¿ø¹®Á¶È¸]
È¿´ÉÈ¿°ú
[ÀûÀÀÁõ º° °Ë»ö]
´ÙÀ½ Áúȯ ¹× Áõ»óÀÇ ÁøÅë ¤ý ¼Ò¿° : ÅðÇ༺°üÀý¿°(°ñ°üÀý¿°), ¾î±ú°üÀýÁÖÀ§¿°, °Ç ¤ý °ÇÃÊ¿°, »ó¿Ï°ñ»ó°ú¿°(Å״Ͻº ¿¤º¸¿ì µî), ±ÙÀ°Åë, ¿Ü»óÈÄÀÇ Á¾Ã¢ ¤ý µ¿Åë
¿ë¹ý¿ë·®
* Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù.
[󹿾à¾î]
¾à¸éÀÇ ¹Ú¸®Áö¸¦ ¶¼¾î³½ ÈÄ 1ÀÏ 2ȸ ȯºÎ¿¡ ºÎÂøÇÑ´Ù.
±Ý±â
1) ÀÌ ¾à ¹× ±âŸÀÇ Ç÷縣ºñÇÁ·ÎÆæ Á¦Á¦¿¡ °ú¹ÎÁõÀÇ º´·ÂÀÌ Àִ ȯÀÚ
2) ¾Æ½ºÇǸ° õ½Ä(ºñ½ºÅ×·ÎÀ̵强 ¼Ò¿°(Ç׿°)ÁøÅëÁ¦ µî¿¡ ÀÇÇÑ Ãµ½Ä¹ßÀÛÀÇ À¯¹ß) ¶Ç´Â ±× º´·ÂÀÌ Àִ ȯÀÚ(õ½Ä¹ßÀÛÀ» À¯¹ßÇÏ´Â °æ¿ì°¡ ÀÖ´Ù.)
½ÅÁßÅõ¿©
±â°üÁö õ½Ä ȯÀÚ(õ½Ä¹ßÀÛÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.)
ÀÌ»ó¹ÝÀÀ
1) ¶§¶§·Î ¹ßÀû(ÃæÇ÷µÇ¾î ºÓ¾îÁü), ¹ßÁø, ¾àÁø(¾à¹°¹ßÁø), °¡·Á¿ò ¹× ÀÛ¿°¨(Ȳö°¨), Á¢ÃËÇǺο°ÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ Áõ»óÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â »ç¿ëÀ» ÁßÁöÇÑ´Ù.
2) õ½Ä¹ßÀÛÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¹Ç·Î °Ç¼º ¼öÆ÷À½(°Åǰ¼Ò¸®), õ¸í(¼ûÀ» ½Ù½Ù°Å¸²), È£Èí°ï¶õ µîÀÇ ÃʱâÁõ»óÀÌ ³ªÅ¸³¯ °æ¿ì¿¡´Â »ç¿ëÀ» ÁßÁöÇÑ´Ù. õ½Ä¹ßÀÛÀº ÀÌ ¾àÀÇ ºÎÂø ÈÄ ¼ö½Ã°£ ³»¿¡ ³ªÅ¸³´Ù.
Related FDA Approved Drug
Á¤º¸¿ä¾à
µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
ÄÚµå ¹× ºÐ·ùÁ¤º¸
Á¦Ç°Á¤º¸
º¹¾àÁ¤º¸
Ç׸ñ
³»¿ë
LACTmed ¹Ù·Î°¡±â
[¹Ù·Î°¡±â]
¾à¸®ÀÛ¿ë
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
Ãà¾àº¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º¹¾àÁöµµ
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
ÀӺο¡´ëÇÑÅõ¿©
*
ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù.
 
FDA : Cµî±Þ
(ÀÓ»ó ¿¬±¸¿¡¼ ÀӽŠ1±â¿Í 3±â¿¡ À§Ç輺 º¸°íµÊ. -Briggs G, et al. Drugs in Pregnancy and Lactation 7th edit. )
*
»ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
*
¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
Pharmacokinetics
À¯·áÁ¤º¸ÀÔ´Ï´Ù.
º¸°ü»ó ÁÖÀÇ
Á¶Á¦½Ã ÁÖÀÇ
½É»çÁ¤º¸
ÇмúÁ¤º¸
Ç׸ñ
³»¿ë
DUR (ÀǾàǰ»ç¿ëÆò°¡)
º´¿ë±Ý±â :
°í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]
¿¬·É´ë±Ý±â :
°í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
[¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
Mechanism of Action
Flurbiprofen¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ The antiinflammatory effect of flurbiprofen may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. Flurbiprofen also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets.
Pharmacology
Flurbiprofen¿¡ ´ëÇÑ Pharmacology Á¤º¸ Flurbiprofen, a nonsteroidal antiinflammatory drug (NSAID) of the propionic acid class, is used for the relief of pain and inflammation associated with rheumatoid arthritis and osteoarthritis and for the inhibition of intraoperative miosis. Flurbiprofen exhibits antiinflammatory, analgesic, and antipyretic activities.
Absorption
Flurbiprofen¿¡ ´ëÇÑ Absorption Á¤º¸ The mean oral bioavailability of flurbiprofen from tablets is 96% relative to an oral solution.
Pharmacokinetics
FlurbiprofenÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á
ÀÛ¿ë¹ßÇö½Ã°£ : 1-2 ½Ã°£ À̳»
Toxicity
Flurbiprofen¿¡ ´ëÇÑ Toxicity Á¤º¸ LD50 =10 mg/kg (orally in dogs).
Drug Interactions
Flurbiprofen¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Alendronate Increased risk of gastric toxicityMethotrexate The NSAID increases the effect and toxicity of methotrexateAnisindione The NSAID increases the anticoagulant effectDicumarol The NSAID increases the anticoagulant effectAcenocoumarol The NSAID increases the anticoagulant effectWarfarin The NSAID increases the anticoagulant effectCyclosporine Monitor for nephrotoxicity
CYP450 Drug Interaction
[CYP450 TableÁ÷Á¢Á¶È¸]
Drug Target
[Drug Target]
Description
Flurbiprofen¿¡ ´ëÇÑ Description Á¤º¸ An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting carbonic anhydrase. [PubChem]
Dosage Form
Flurbiprofen¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Capsule, extended release OralLiquid OphthalmicTablet Oral
Drug Category
Flurbiprofen¿¡ ´ëÇÑ Drug_Category Á¤º¸ AnalgesicsAnti-Inflammatory Agents, Non-SteroidalAnti-inflammatory AgentsCarbonic Anhydrase InhibitorsCyclooxygenase InhibitorsNonsteroidal Antiinflammatory Agents (NSAIDs)
Smiles String Canonical
Flurbiprofen¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC(C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
Smiles String Isomeric
Flurbiprofen¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ C[C@@H](C(O)=O)C1=CC(F)=C(C=C1)C1=CC=CC=C1
InChI Identifier
Flurbiprofen¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/f/h17H
Chemical IUPAC Name
Flurbiprofen¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ 2-(3-fluoro-4-phenylphenyl)propanoic acid
»ç¿ëÀÚÄÁÅÙÃ÷
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-04-04
º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
¾Ë¸²
»ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.
°æ°í
µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù.
Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â
Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡± ¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é
¿©±â ·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ